PE20170902A1 - Composicion dietetica con actividad antidislipidemica - Google Patents

Composicion dietetica con actividad antidislipidemica

Info

Publication number
PE20170902A1
PE20170902A1 PE2016002766A PE2016002766A PE20170902A1 PE 20170902 A1 PE20170902 A1 PE 20170902A1 PE 2016002766 A PE2016002766 A PE 2016002766A PE 2016002766 A PE2016002766 A PE 2016002766A PE 20170902 A1 PE20170902 A1 PE 20170902A1
Authority
PE
Peru
Prior art keywords
antidislipidemic
activity
dietary composition
composition
dietary
Prior art date
Application number
PE2016002766A
Other languages
English (en)
Inventor
Alida Agostini
Francesco Melani
Original Assignee
Berlin-Chemie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlin-Chemie Ag filed Critical Berlin-Chemie Ag
Publication of PE20170902A1 publication Critical patent/PE20170902A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

SE REFIERE A UNA COMPOSICION DIETETICA QUE COMPRENDE: A) DE 50 A 600 MG DE LEVADURA DE ARROZ ROJO QUE CONTIENE MEVINOLINA ENTRE 0.05% Y 5% POR PESO; B) DE 1 A 50 MG DE POLICOSANOLES; C) DE 4 A 100 MG DE NIACINA; D) DE 500 A 1000 MG DE ESTEROLES Y/O ESTANOLES; E) ACIDO FOLICO Y SUS DERIVADOS, VITAMINAS B6, B12 Y E; Y F) EXCIPIENTES FARMACEUTICAMENTE ACEPTABLES. DICHA COMPOSICION ESTA EN FORMA DE TABLETA, SUSPENSION LIQUIDA, ENTRE OTROS, SIENDO UTIL EN EL TRATAMIENTO DE DISLIPIDEMIA
PE2016002766A 2014-07-18 2015-07-17 Composicion dietetica con actividad antidislipidemica PE20170902A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM20140401 2014-07-18

Publications (1)

Publication Number Publication Date
PE20170902A1 true PE20170902A1 (es) 2017-07-12

Family

ID=51655865

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2016002766A PE20170902A1 (es) 2014-07-18 2015-07-17 Composicion dietetica con actividad antidislipidemica

Country Status (22)

Country Link
EP (1) EP3169322B1 (es)
KR (1) KR102440770B1 (es)
CN (1) CN106659679A (es)
AU (1) AU2015291203B2 (es)
CO (1) CO2017001560A2 (es)
CY (1) CY1124324T1 (es)
DK (1) DK3169322T3 (es)
ES (1) ES2833323T3 (es)
HR (1) HRP20201824T1 (es)
HU (1) HUE052786T2 (es)
LT (1) LT3169322T (es)
MA (1) MA39566A1 (es)
MX (1) MX380116B (es)
MY (1) MY186102A (es)
PE (1) PE20170902A1 (es)
PL (1) PL3169322T3 (es)
PT (1) PT3169322T (es)
RS (1) RS61160B1 (es)
SG (1) SG11201700417XA (es)
SI (1) SI3169322T1 (es)
SM (1) SMT202000658T1 (es)
WO (1) WO2016009403A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111629784A (zh) * 2018-01-04 2020-09-04 纯护理专业有限责任公司 用于调节总血液胆固醇的天然组合产品和方法
WO2020208404A1 (en) * 2019-04-11 2020-10-15 Pharmanutrition R&D S.r.l. A highly available powder composition containing red rice
GB202200008D0 (en) * 2022-01-01 2022-02-16 Meda Pharma S P A Compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2488617A1 (en) * 2002-06-10 2003-12-18 Eugene R. Cooper Nanoparticulate sterol formulations and sterol combinations
CN1672712A (zh) * 2004-03-25 2005-09-28 李安国 降低血脂的新组方及其制剂制备方法
US20080103118A1 (en) 2006-10-27 2008-05-01 Iomedix Development International Srl Composition for improving blood cholesterol levels
US8815310B2 (en) * 2011-01-10 2014-08-26 Morteza Naghavi Compositions for boosting metabolism, assisting weight loss, and promoting cardiovascular health
US20120270849A1 (en) 2011-04-20 2012-10-25 Prosoft Software, Inc. Combinations of niacin, omega-3 and plant sterols/stanols for prevention cholesterol treatment
EP2744355B1 (en) 2011-08-15 2016-09-21 Unilever N.V. Edible composition comprising sterol

Also Published As

Publication number Publication date
AU2015291203A1 (en) 2017-03-09
SI3169322T1 (sl) 2021-01-29
CY1124324T1 (el) 2022-03-24
PL3169322T3 (pl) 2021-04-19
MA39566A1 (fr) 2018-08-31
SMT202000658T1 (it) 2021-01-05
CO2017001560A2 (es) 2017-05-19
DK3169322T3 (da) 2020-11-16
NZ729232A (en) 2022-03-25
HRP20201824T1 (hr) 2021-01-08
KR102440770B1 (ko) 2022-09-06
EP3169322A1 (en) 2017-05-24
PT3169322T (pt) 2020-12-04
WO2016009403A1 (en) 2016-01-21
RS61160B1 (sr) 2021-01-29
KR20170030641A (ko) 2017-03-17
EP3169322B1 (en) 2020-09-09
CN106659679A (zh) 2017-05-10
LT3169322T (lt) 2020-12-10
ES2833323T3 (es) 2021-06-14
MX380116B (es) 2025-03-11
HUE052786T2 (hu) 2021-05-28
MX2017000740A (es) 2017-10-12
MY186102A (en) 2021-06-22
AU2015291203B2 (en) 2020-03-12
SG11201700417XA (en) 2017-02-27

Similar Documents

Publication Publication Date Title
IL269444B (en) New modified indazoles, methods for their production, pharmaceutical preparations containing the new modified indazoles, and the use of the new modified indazoles in the production of drugs
EP3600563C0 (en) PHARMACEUTICAL COMPOSITIONS COMPRISING VITAMIN D3 AND HYALURONIC ACID
MX382033B (es) Compuestos heterocíclicos para utilizarlos en el tratamiento de trastornos mediados por pi3k-gamma.
CL2018000739A1 (es) Terapia adjuntiva con 25-hidroxi vitamina d y artículos de la misma.
MA39710A (fr) Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
CL2016001094A1 (es) Silicato de zirconio microporoso para el tratamiento de hipercalemia.
EA201790726A1 (ru) Фармацевтическая композиция для лечения язвенного колита
CO2017005544A2 (es) Tableta multicapa que contiene fármaco inestable a la luz
IN2014MU01042A (es)
PE20170902A1 (es) Composicion dietetica con actividad antidislipidemica
TR201908151T4 (tr) İzoindolin türevleri.
HUE064808T2 (hu) Prekurzor vegyületek az A5-vitamin útvonal retinoidjainak elõállítására és azok alkalmazása
EP3237377A4 (en) Vitamin d3 derivatives and pharmaceutical use thereof
EP3215128A4 (en) Oral administration of unstable or poorly-absorbed drugs
CL2017000026A1 (es) Formas de dosificación farmacéutica
CL2016001752A1 (es) Administración de vitamina b6 materna para la prevención del aumento de la adiposidad, el sobrepeso o la obesidad en la descendencia
AR100153A1 (es) Medicamento
NZ739679A (en) Cholecalciferol sulfate salts and their use for the treatment of vitamin d deficiency
BR112017009743A2 (pt) produto de bebida com tartarato de sódio e potássio
MX2016010104A (es) Uso de paricalcitol en el tratamiento de la anemia inflamatoria.
NZ727876A (en) Misoprostol dispersible tablet
UA97716U (uk) Лікарський засіб у формі сиропу, що містить фенспіриду гідрохлорид
PH22014000055Y1 (en) A composition for a vitamin supplement containing calcium, vitamin c and vitamin d3 for better absorption
TWD190076S (zh) bottle
MX2016002509A (es) Composicion farmaceutica de la combinacion de desloratadina con montelukast para ser administrada por via oral en forma farmaceutica tableta o en granulado, para el tratamiento de enfermedades respiratorias.